FR2969492B1 - Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene - Google Patents

Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene

Info

Publication number
FR2969492B1
FR2969492B1 FR1061167A FR1061167A FR2969492B1 FR 2969492 B1 FR2969492 B1 FR 2969492B1 FR 1061167 A FR1061167 A FR 1061167A FR 1061167 A FR1061167 A FR 1061167A FR 2969492 B1 FR2969492 B1 FR 2969492B1
Authority
FR
France
Prior art keywords
dermatological
gel
suspension containing
foams obtained
containing adapalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1061167A
Other languages
English (en)
Other versions
FR2969492A1 (fr
Inventor
Emmanuelle At
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR1061167A priority Critical patent/FR2969492B1/fr
Priority to CA2822546A priority patent/CA2822546A1/fr
Priority to US13/997,164 priority patent/US9271930B2/en
Priority to PCT/FR2011/053159 priority patent/WO2012085481A1/fr
Priority to EP11815527.4A priority patent/EP2654717A1/fr
Publication of FR2969492A1 publication Critical patent/FR2969492A1/fr
Application granted granted Critical
Publication of FR2969492B1 publication Critical patent/FR2969492B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
FR1061167A 2010-12-23 2010-12-23 Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene Active FR2969492B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1061167A FR2969492B1 (fr) 2010-12-23 2010-12-23 Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
CA2822546A CA2822546A1 (fr) 2010-12-23 2011-12-22 Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
US13/997,164 US9271930B2 (en) 2010-12-23 2011-12-22 Dermatological foams obtained from a gel or suspension containing adapalene
PCT/FR2011/053159 WO2012085481A1 (fr) 2010-12-23 2011-12-22 Mousses dermatologiques obtenues à partir d'un gel ou d'une suspension contenant de l'adapalène
EP11815527.4A EP2654717A1 (fr) 2010-12-23 2011-12-22 Mousses dermatologiques obtenues à partir d'un gel ou d'une suspension contenant de l'adapalène

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1061167A FR2969492B1 (fr) 2010-12-23 2010-12-23 Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene

Publications (2)

Publication Number Publication Date
FR2969492A1 FR2969492A1 (fr) 2012-06-29
FR2969492B1 true FR2969492B1 (fr) 2013-07-05

Family

ID=44177437

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1061167A Active FR2969492B1 (fr) 2010-12-23 2010-12-23 Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene

Country Status (5)

Country Link
US (1) US9271930B2 (fr)
EP (1) EP2654717A1 (fr)
CA (1) CA2822546A1 (fr)
FR (1) FR2969492B1 (fr)
WO (1) WO2012085481A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
WO2011013008A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
WO2015144905A1 (fr) 2014-03-28 2015-10-01 Galderma Research & Development Mousse chimique rincée contenant du peroxyde de benzoyle
JP2017508762A (ja) 2014-03-28 2017-03-30 ガルデルマ・リサーチ・アンド・デヴェロップメント 過酸化ベンゾイルを含有するすすがない化学的ムース剤
US20180185283A1 (en) * 2014-03-28 2018-07-05 Galderma Research & Development Non-rinse chemical mousse containing adapalene and benzoyl peroxide
FR3041535B1 (fr) 2015-09-29 2019-01-25 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041536B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041539B1 (fr) 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041538B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041541B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
FR3041537B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US9987239B1 (en) 2017-03-14 2018-06-05 Rey Ventures, LLC Pharmaceutical retinoid preparation for topical use
US10506196B2 (en) * 2017-04-01 2019-12-10 Intel Corporation 360 neighbor-based quality selector, range adjuster, viewport manager, and motion estimator for graphics
CN113577022B (zh) * 2021-05-18 2023-03-17 南京欣通瑞亿医药科技有限公司 一种氨苯砜类化合物混悬液及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
MXPA04008684A (es) * 2002-03-12 2004-12-06 Galderma Res & Dev Uso de adapaleno para tratamiento de trastornos dermatologicos.
EP1536763B1 (fr) * 2002-09-05 2007-07-11 Galderma Research & Development Composition de depigmentation pour la peau comprenant de l'adapalene et au moins un agent de depigmentation
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
PL2206494T3 (pl) * 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Spienialny żel zawiesinowy
FR2901701B1 (fr) * 2006-05-31 2010-10-29 Galderma Res & Dev Compostions comprenant au moins un derive de l'acide naphtoique et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
CA2656451C (fr) * 2006-07-13 2015-01-27 Galderma Research & Development Composition comprenant un retinoide et du peroxyde de benzoyle
MX2009000507A (es) * 2006-07-14 2009-06-12 Stiefel Res Australia Pty Ltd Espuma farmaceutica de acidos grasos.
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
EP2065032A1 (fr) * 2007-11-27 2009-06-03 Galderma Research & Development Procédé pour la production de gels d'adapalène

Also Published As

Publication number Publication date
US9271930B2 (en) 2016-03-01
FR2969492A1 (fr) 2012-06-29
CA2822546A1 (fr) 2012-06-28
EP2654717A1 (fr) 2013-10-30
WO2012085481A1 (fr) 2012-06-28
US20130338230A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
FR2969492B1 (fr) Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969491B1 (fr) Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
FR2969493B1 (fr) Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
WO2011150133A3 (fr) Protéines d'échafaudage à base de fibronectine ayant une stabilité améliorée
EP3722320A3 (fr) Anticorps c1s anti-complément et leurs utilisations
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
GB201020193D0 (en) Glucan compositions
WO2012088266A3 (fr) Imidazopyridazines et benzimidazoles substitués en tant qu'inhibiteurs de fgfr3
BR112012032028A2 (pt) compostos de tioacetato, composições e métodos de uso.
MX354506B (es) Pirazolopirimidinas sustituidas como activadores de glucocerebrosidasa.
BR112014016647A8 (pt) estruturas fibrosas compreendendo partículas e métodos de produção das mesmas
MX2009004664A (es) Inmunoglobulinas hibridas con partes moviles.
TN2012000512A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
TN2012000511A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
EP2576578A4 (fr) Formes polymorphiques du 2'-o-fucosyllactose et leurs procédés de production
MX2019000225A (es) Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades.
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
WO2008085221A3 (fr) Utilisation thérapeutique de cellules exprimant cd31
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
MX2012015203A (es) Composiciones transparentes de limpieza de baja irritacion con ph relativamente bajo.
PH12014501369A1 (en) Oral care compositions
EP2575833A4 (fr) Amibes thérapeutiques et leurs utilisations
MX2013008046A (es) Hidrogeles a base de esteres de acido poliisobutenosuccinico.
MX2016007436A (es) Composiciones para el cuidado oral que comprenden carbonato de calcio y talco.
FR2949782B1 (fr) Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14